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A variety of diacylglycerol (DG) molecular species are produced in stimulated cells. Conventional (α, βII
and γ) and novel (δ, ε, η and θ) protein kinase C (PKC) isoforms are known to be activated by DG.
However, a comprehensive analysis has not been performed. In this study, we analyzed activation of the
PKC isozymes in the presence of 2–2000 mmol% 16:0/16:0-, 16:0/18:1-, 18:1/18:1-, 18:0/20:4- or 18:0/
22:6-DG species. PKCα activity was strongly increased by DG and exhibited less of a preference for 18:0/
22:6-DG at 2 mmol%. PKCβII activity was moderately increased by DG and did not have signiﬁcant
preference for DG species. PKCγ activity was moderately increased by DG and exhibited a moderate
preference for 18:0/22:6-DG at 2 mmol%. PKCδ activity was moderately increased by DG and exhibited a
preference for 18:0/22:6-DG at 20 and 200 mmol%. PKCε activity moderately increased by DG and
showed a moderate preference for 18:0/22:6-DG at 2000 mmol%. PKCη was not markedly activated by
DG. PKCθ activity was the most strongly increased by DG and exhibited a preference for 18:0/22:6-DG at
2 and 20 mmol% DG. These results indicate that conventional and novel PKCs have different sensitivities
and dependences on DG and a distinct preference for shorter and saturated fatty acid-containing and
longer and polyunsaturated fatty acid-containing DG species, respectively. This differential regulation
would be important for their physiological functions.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Diacylglycerol (DG) serves to activate a variety of signaling
proteins, including protein kinase C (PKC) [1–5]. PKC is involved in
receptor desensitization, in modulating membrane structure
events, in regulating transcription, in mediating immune re-
sponses, in regulating cell growth, and in learning and memory
among many other functions. PKC is a family of closely related
serine/threonine kinases, and at least ten different isoforms have
been discovered to date. The isoforms can be split into three fa-
milies according to their requirement for different co-factors: the
conventional or classical (c) PKCs: α, βI/βII and γ; novel (n) PKCs:
δ, ε, η and θ; and the atypical (a) PKCs: ζ and λ. cPKCs can be
activated by Ca2þ and by DG. nPKCs can also be activated by DG.
However, aPKCs are unresponsive to Ca2þ or DG.
DG kinase (DGK) phosphorylates DG to produce phosphatidic
acid [6–9]. To date, 10 mammalian DGK isozymes have been
identiﬁed, and these isozymes are subdivided into ﬁve groupsB.V. This is an open access article u
C; DG, diacylglycerol; DGK,
ent 4-14; nPKC, novel pro-
ecanoylphorbol-13-acetate
ne).according to their structural features. DGK isozymes are also in-
volved in regulating cell growth [10–12] and angiogenesis [13],
mediating immune responses [14–16], exacerbating the severity of
type-2 diabetes [17–19] and controlling neuronal network forma-
tion [20–23]. Because DGK consumes an activator of PKC, DG, DGK
regulates (attenuates) cPKC and nPKC activities. Indeed, many
functional linkages between PKC isozymes and DGK isozymes have
been reported [6–9].
Mammalian cells contain at least 50 structurally distinct DG
molecular species, which are supplied from a variety of lipid me-
tabolic pathways, such as phosphatidylinositol turnover [24],
phosphatidylcholine (PC) hydrolysis by PC-speciﬁc phospholipase
C [25,26] and PC hydrolysis by phospholipase D followed by de-
phosphorylation by phosphatidic acid phosphatase [27] in a cell
stimulation-dependent manner. The DG species generated
through phosphatidylinositol turnover mainly consists of 18:0/
20:4-DG. The DG species derived from PC predominantly contain
saturated and monounsaturated fatty acids.
DGKε has preference for 18:0/20:4-DG in vitro [28,29]. Our
recent studies reported that several isozymes of DGK selectively
metabolize different DG species within the cell. For example,
DGKα was suggested to phosphorylate 18:0/20:4-DG and 18:0/
22:6-DG in T-lymphocytes and COS-7 cells [30,31]. DGKδ utilized
PC-derived 14:0/16:0-, 14:0/16:1-, 16:0/16:0-, 16:0/16:1-, 16:0/nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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results, the possibility that each DGK isozymes metabolizes limited
DG species and regulates the activity of restricted PKC isozymes
has been suggested. However, a comprehensive analysis of the DG
dependency of all cPKC and nPKC isozymes has not been per-
formed. It was reported that the in vitro activation of different PKC
isozymes varies in response to different DG species [32]. However,
in this report, only PKCα, βI, γ, δ and ε were analyzed, and only
8:0/8:0-, which is not a natural product, 18:0/20:4-, 18:0/20:5- and
18:0/22:6-DG (50–1000 mmol%) were used.
Therefore, in this study, we more comprehensively re-eval-
uated the effects of 16:0/16:0-, 16:0/18:1-, 18:1/18:1-, 18:0/20:4- or
18:0/22:6-DG species in concentrations ranging from 2 to
2000 mmol% on all cPKC and nPKC isozymes side by side under
the same conditions and aimed to obtain fundamental knowledge
to explore the relationship between PKC isozyme activation and
DG-related enzymes, including DGK isozymes. The obtained re-
sults indicate that, beyond our expectations, the modes of activa-
tion of cPKC and nPKC isozymes by DG molecular species varied
considerably.Fig. 1. Effects of different DG molecular species on PKCα activation. Lipid vesicles
were prepared with different DG molecular species (16:0/16:0-, 16:0/18:1-, 18:1/
18:1-, 18:0/20:4- and 18:0/22:6-DG) and PKC activity toward MBP was determined
in vesicles as a function of increasing concentrations of DGs, as described in Section
2.The results are the means7SD of four independent experiments. The left axis
shows the relative activity compared to the control (0 mmol% DG) and the right
axis shows the speciﬁc activity. The data are signiﬁcantly different from the control,
0 mmol% DG (*Po0.05, **Po0.01, ***Po0.005), and among the DG molecular
species (#Po0.05).2. Materials and methods
2.1. Materials
1,2-dipalmitoyl-sn-glycerol (16:0/16:0-DG), 1-palmitoyl-2-
oleoyl-sn-glycerol (16:0/18:1-DG), 1,2-dioleoyl-sn-glycerol (18:1/
18:1-DG), 1-stearoyl-2-docosahexaenoyl-sn-glycerol (18:0/22:6-
DG) and phosphatidylserine (PS) were purchased from Avanti
Polar Lipids (Alabaster, AL).1-stearoyl-2-arachidonoyl-sn-glycerol
(18:0/20:4-DG) and the PKC substrate, the [pGlu4]-Myelin basic
protein fragment 4-14 (MBP) was obtained from Sigma-Aldrich (St.
Louis, MO). PKC isoforms (α (product number: 01-133), βΙΙ (01-
165), γ (01-137), δ (01-135), ε (01-136), η (01-138) and θ (01-140))
were obtained from Carna Biosciences (Kobe, Japan). These PKC
isoforms were expressed as N-terminal Glutathione S-transferase-
fusion proteins using baculovirus expression system and were
highly puriﬁed by using glutathione Sepharose chromatography.
P81 phosphocellulose squares were obtained from Merck Milli-
pore (Darmstadt, Germany).
2.2. PKC activity assay
PKC activity was assayed by measuring the incorporation of 32P
from [γ-32P] ATP into [pGlu4]-Myelin basic protein fragment 4-14
(pGlu-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu). The reaction
mixture (12.5 μl) contained 24 mM Tris-HCl (pH 7.4), 20 mM
MgCl2, 0.2 mM CaCl2 (for α, βΙΙ, and γ) or 0.5 mM EDTA (for δ, ε, η
and θ), 56 mg/ml MBP, 0.05 μg of PKC, 2 mol% PS, and 2–
2000 mmol% DG. PS and DG were ﬁrst mixed in chloroform/me-
thanol and then dried under nitrogen. The residue was then so-
nicated in a buffer solution containing 255 mM Triton X-100 and
10 mM Tris–HCl to prepare lipid vesicles. The reaction was started
by the addition of 0.1 mM [γ-32P] ATP (∼300 cpm/pmol), con-
tinued for 10 min at 30 °C and stopped by spotting 10 μl of sam-
ples on 0.50.5 cm squares of Whatman P81 phosphocellulose
paper. The papers were dried, washed four times for 15 min each
time with 1% H3PO4, and transferred to a scintillation counter to
determine the radioactivity of [32P] MBP.
2.3. Cell culture and transfection
COS-7 cells were maintained in Dulbecco's Modiﬁed Eagle's
Medium (Wako Pure Chemical Industries, Osaka, Japan) containing
10% fetal bovine serum at 37 °C in an atmosphere containing 5%CO2. The cells were transfected with pEGFP-N3-PKCη by electro-
poration (1106 cells/2 mm gap cuvette, 110 V, 20.0 ms pulse
length, one pulse) with the Gene Pulser Xcell™ Electroporation
System (Bio-Rad Laboratories, Tokyo, Japan), according to the
manufacturer's instructions. Forty-eight hours after transfection,
the cells were harvested and suspended in 500 μl of ice-cold lysis
buffer (50 mM HEPES (pH 7.2), 150 mM NaCl, 5 mM MgCl2, 1 mM
dithiothreitol, and cOmplete™ EDTA-free protease inhibitor cock-
tail (Roche Diagnostics, Tokyo, Japan)) and then sonicated. The
mixtures were centrifuged at 10,000 g for 5 min at 4 °C to yield
cell lysates. EGFP-PKCη expression was conﬁrmed by Western
blotting using an anti-GFP antibody (sc-9996, Santa Cruz Bio-
technology, Santa Cruz, CA).
2.4. Statistical analysis
Statistical comparisons were performed using one-way ANOVA
followed by Tukey's post hoc test.3. Results
3.1. Effects of different DG species on PKCα activation
We measured the activation of highly puriﬁed cPKC and nPKC
isozymes in the presence of 16:0/16:0-, 16:0/18:1-, 18:1/18:1-,
18:0/20:4- or 18:0/22:6-DG species in concentrations ranging from
2 to 2000 mmol%. The reason in choosing the concentration range
of DG in the study is that DG produced by cell stimulation is ap-
proximately 20 mmol% [33]. We analyzed (1) the sensitivity of
cPKC and nPKC isozymes to DG (DG concentration for PKC acti-
vation), (2) their dependence on DG (fold increase of PKC activity
by DG), and (3) preference for DG species.
We ﬁrst examined effects of different DG species on the activity
of a cPKC, PKCα. PKCα activity was increased approximately 2-fold
in the presence of 2 mmol% 16:0/16:0-, 16:0/18:1-, 18:1/18:1-,
18:0/20:4-DG (Fig. 1). However, 2 mmol% 18:0/22:6-DG did not
signiﬁcantly activate PKCα. PKCα activity was increased by DG in a
dose dependent manner and was increased approximately 2.5-,
3.5- and 7-fold by 20, 200 and 2000 mmol% DG, respectively.
However, PKCα did not exhibit preference for DG species at 20–
2000 mmol%. Taken together, these results indicate that PKCα has
Fig. 3. Effects of different DG molecular species on PKCγ activation. Lipid vesicles
were prepared with different DG molecular species (16:0/16:0-, 16:0/18:1-, 18:1/
18:1-, 18:0/20:4- and 18:0/22:6-DG) and PKC activity toward MBP was determined
in vesicles as a function of increasing concentrations of DGs, as described in Section
2. The results are the means7SD of ﬁve independent experiments. The left axis
shows the relative activity compared to the control (0 mmol% DG) and the right
axis shows the speciﬁc activity. The data are signiﬁcantly different from the control,
0 mmol% DG (*Po0.05, **Po0.01, ***Po0.005), and among the DG molecular
species (#Po0.05).
Table 1
Summary of the effects of different DG molecular species on the activity of cPKC
and nPKC isozymes.
[DG] (mmol%)
2 20 200 2000
PKCα Fold increase þ þ þþ þþþ
Preference DP4SD   
PKCβΙΙ Fold increase þ þ þ þþ
Preference    
PKCγ Fold increase þ þ þ þþ
Preference DPoSD   
PKCδ Fold increase  þ þþ þþ
Preference  DPoSD DPoSD 
PKCε Fold increase  þ þ þþ
Preference    DPoSD
PKCη Fold increase    
Preference    
PKCη expressed in COS-
7 cells
Fold increase  þ þ þ
Preference  DPoSD  
PKCθ Fold increase þþ þþþ þþþþ þþþþ
Preference DPoSD   
Fold increase: –, less than 1.5-fold; þ , more than 1.5-fold; þþ , more than 3-fold;
þþþ , more than 6-fold; þþþþ , more than 12-fold.
Preference: different preference for 16:0/16:0-DG (1,2-dipalmitoyl-sn-glycerol
(DP)) and 18:0/22:6-DG (1-stearyl-2-docosahexanoyl-sn-glycerol (SD)).
Y. Kamiya et al. / Biochemistry and Biophysics Reports 7 (2016) 361–366 363(1) a high sensitivity to DG, (2) a strong dependence on DG and
(3) less of a preference for 18:0/22:6-DG at low DG concentrations
(Table 1).
3.2. Effects of different DG species on PKCβII activation
Differential splicing gives rise to the two forms of PKCβ, βI and
βII, which only differ in their extreme C-terminal ends [34]. We
next tested the effects of different DG species on the activity of a
cPKC, PKCβII. PKCβII activity was increased approximately 1.5-fold
by 2 mmol% DG, and its activity was increased approximately 1.5-,
2- and 4-fold by 20, 200 and 2000 mmol% DG, respectively (Fig. 2).
However, PKCβII did not show signiﬁcant preference for either
18:0/22:6-DG or 16:0/16:0-DG at 2–2000 mmol%. Taken together,
these results indicate that PKCβII has (1) a high sensitivity to DG,
(2) a moderate dependence on DG and (3) no signiﬁcant pre-
ference for DG molecular species (Table 1).Fig. 2. Effects of different DG molecular species on PKCβΙΙ activation. Lipid vesicles
were prepared with different DG molecular species (16:0/16:0-, 16:0/18:1-, 18:1/
18:1-, 18:0/20:4- and 18:0/22:6-DG) and PKC activity toward MBP was determined
in vesicles as a function of increasing concentrations of DGs, as described in Section
2. The results are the means 7 SD of three independent experiments. The left axis
shows the relative activity compared to the control (0 mmol% DG) and the right
axis shows the speciﬁc activity. The data are signiﬁcantly different from the control,
0 mmol% DG (*Po0.05, **Po0.01, ***Po0.005).3.3. Effects of different DG species on PKCγ activation
PKCγ (cPKC) activity was increased approximately 1.5-fold in
the presence of 2 mmol% 18:0/22:6-DG (Fig. 3). However, 2 mmol%
16:0/16:0-, 16:0/18:1-, 18:1/18:1-, and 18:0/20:4-DG failed to sig-
niﬁcantly activate PKCγ. PKCγ activity was increased approxi-
mately 2-, 2.5- and 6-fold by 20, 200 and 2000 mmol% DG, re-
spectively. However, PKCγ did not exhibit a signiﬁcant preference
for DG species at 20–2000 mmol%. These results indicate that
PKCγ has (1) a high sensitivity to DG, (2) a moderate dependence
on DG and, (3) in contrast to PKCα, a moderate preference for 18:0/
22:6-DG at low DG concentrations (Table 1).
3.4. Effects of different DG species on activation of PKCδ
We next tested the effects of different DG species on the ac-
tivity of an nPKC, PKCδ. PKCδ was not signiﬁcantly activated by
2 mmol% DG (Fig. 4). However, the activity of this isozyme was
increased approximately 2.5-fold by 20 mmol% DG, and its activity
was increased approximately 5- and 5.5-fold by 200 and
2000 mmol% DG, respectively. 16:0/18:1-, 18:0/20:4- and 18:0/
22:6-DG strongly activated PKCδ compared to 16:0/16:0-DG atFig. 4. Effects of different DG molecular species on PKCδ activation. Lipid vesicles
were prepared with different DG molecular species (16:0/16:0-, 16:0/18:1-, 18:1/
18:1-, 18:0/20:4- and 18:0/22:6-DG) and PKC activity toward MBP was determined
in vesicles as a function of increasing concentrations of DGs, as described in Section
2. The results are the means7SD of four independent experiments. The left axis
shows the relative activity compared to the control (0 mmol% DG) and the right
axis shows the speciﬁc activity. The data are signiﬁcantly different from the control,
0 mmol% DG (*Po0.05, **Po0.01, ***Po0.005), and among the DG molecular
species (#Po0.05, ##Po0.01).
Fig. 5. Effects of different DG molecular species on PKCε activation. Lipid vesicles
were prepared with different DG molecular species (16:0/16:0-, 16:0/18:1-, 18:1/
18:1-, 18:0/20:4- and 18:0/22:6-DG) and PKC activity toward MBP was determined
in vesicles as a function of increasing concentrations of DGs, as described in Section
2. The results are the means7SD of four independent experiments. The left axis
shows the relative activity compared to the control (0 mmol% DG) and the right
axis shows the speciﬁc activity. The data are signiﬁcantly different from the control,
0 mmol% DG (*Po0.05, **Po0.01, ***Po0.005), and among the DG molecular
species (#Po0.05).
Fig. 6. Effects of different DG molecular species on PKCη activation. Lipid vesicles
were prepared with different DG molecular species (16:0/16:0-, 16:0/18:1-, 18:1/
18:1-, 18:0/20:4- and 18:0/22:6-DG) and PKC activity toward MBP was determined
in vesicles as a function of increasing concentrations of DGs, as described in Section
2. The results are the means7SD of four independent experiments. The left axis
shows the relative activity compared to the control (0 mmol% DG) and the right
axis shows the speciﬁc activity.
Fig. 7. Effects of different DG molecular species on the activation of PKCη expressed
in COS-7 cells. Lipid vesicles were prepared with different DG molecular species
(16:0/16:0-, 16:0/18:1-, 18:1/18:1-, 18:0/20:4- and 18:0/22:6-DG) and PKC activity
toward MBP was determined in vesicles as a function of increasing concentrations
of DGs, as described in Section 2. The activities of vector-transfected cells were
subtracted. The results are the means7SD of three independent experiments. The
left axis shows the relative activity compared to the control (0 mmol% DG). The
data are signiﬁcantly different from the control, 0 mmol% DG (*Po0.05, **Po0.01,
***Po0.005), and among the DG molecular species (#Po0.05, ##Po0.01).
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strongly enhanced by 18:0/22:6-DG. However, PKCδ did not ex-
hibit a signiﬁcant difference in the degree of activation by DG
species at 2000 mmol%. These results indicate that PKCδ has (1) a
moderate sensitivity to DG, (2) a moderate dependence on DG,
(3) a preference for 18:0/22:6-DG, and less of a preference for
16:0/16:0-DG at medium concentrations (Table 1).
3.5. Effects of different DG species on PKCε activation
PKCε (nPKC) was not signiﬁcantly activated by 2 mmol% DG
(Fig. 5). However, the activity of this isoform was increased ap-
proximately 1.5-fold by 20 mmol% DG and was increased ap-
proximately 2- and 4-fold by 200 and 2000 mmol% DG, respec-
tively. Although PKCε did not exhibit a signiﬁcant preference for
DG species at 20 and 200 mmol%, this isozyme showed a pre-
ference for 18:0/22:6-DG at 2000 mmol%. These results indicate
that PKCε has (1) a moderate sensitivity to DG, (2) a moderate
dependence on DG and (3) a preference for 18:0/22:6-DG at high
concentrations (Table 1).
3.6. Effects of different DG species on PKCη activation
PKCη (nPKC) was not markedly activated by any DG molecular
species at any concentrations (Fig. 6). 12-O-Tetradecanoylphorbol-
13-acetate (TPA), which mimics DG, is known to strongly activate
cPKC and nPKC isozymes [35]. Although the effect of TPA on the
activity of PKCη was examined, TPA also did not signiﬁcantly ac-
tivate this enzyme (Suppl. Fig. 1).
Given that PKCη expressed in insect cells is not responsive to
DG, we next determined the effects of DG species on this isozyme
expressed in mammalian cells (COS-7 cells) instead of insect cells.
PKCη activation by DG species (approximately 1.5-fold increase)
was detected at 20 mmol% (Fig. 7). This isozyme showed a weak
preference for 18:0/22:6-DG at 20 mmol%. The activity of this
isoform was increased approximately 1.5- and 2.5-fold by 200 and
2000 mmol% DG, respectively. However, PKCη did not show a
signiﬁcant preference for DG molecular species at 200 and
2000 mmol%.
These results indicate that PKCη expressed in insect cells has
(1) no sensitivity to DG, (2) no dependence on DG and (3) no
preference to DG species, even at high concentrations (Table 1). On
the other hand, PKCη expressed in mammalian cells has (1) a
moderate sensitivity to DG, (2) a weak dependence on DG and(3) a weak preference for 18:0/22:6-DG at medium concentrations
(Table 1).
3.7. Effects of different DG species on activation of PKCθ
Finally, we tested the effects of different DG species on the
activity of an nPKC, PKCθ. PKCθ activity was increased approxi-
mately 4-fold by 18:0/22:6-DG at 2 mmol% DG, and its activity was
increased approximately 8-, 21- and 25-fold by all DG species at
20, 200 and 2000 mmol% DG, respectively (Fig. 8). PKCθ was more
strongly activated by 16:0/18:1-DG, 18:0/20:4- and 18:0/22:6-DG
than by 16:0/16:0-DG and by 18:0/22:6-DG than by 16:0/18:1-,
18:1/18:1 and 18:0/20:4-DG at 2 and 20 mmol% DG, respectively.
However, PKCθ did not exhibit a signiﬁcant preference for DG
species at 200 and 2000 mmol%. These results indicate that PKCθ
has (1) a high sensitivity to DG, (2) a very strong dependence on
DG and (3) a preference for 18:0/22:6-DG at relatively low DG
concentrations (Table 1).
Overall, these results indicate that cPKC and nPKC isozymes
have different dependencies/sensitivities to DG and distinct pre-
ferences for shorter and saturated fatty acid-containing DG species
Fig. 8. Effects of different DG molecular species on PKCθ activation. Lipid vesicles
were prepared with different DG molecular species (16:0/16:0-, 16:0/18:1-, 18:1/
18:1-, 18:0/20:4- and 18:0/22:6-DG) and PKC activity toward MBP was determined
in vesicles as a function of increasing concentrations of DGs as described in Section
2. The results are the means 7 SD of three independent experiments. The left axis
shows the relative activity compared to the control (0 mmol% DG) and the right
axis shows the speciﬁc activity. The data are signiﬁcantly different from the control,
0 mmol% DG (*Po0.05, **Po0.01, ***Po0.005), and among the DG molecular
species (#Po0.05, ##Po0.01).
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taining DG species (18:0/22:6-DG), respectively.4. Discussion
A variety of DG molecular species are produced in stimulated
cells. cPKC (α, βII and γ) and nPKC (δ, ε, η and θ) isozymes are
known to be activated by DG [1–5]. However, a comprehensive
analysis of the DG dependency of these PKCs has not been per-
formed. Therefore, we performed comprehensive comparison of
the effects of DG molecular species (2–2000 mmol% 16:0/16:0-,
16:0/18:1-, 18:1/18:1-, 18:0/20:4- or 18:0/22:6-DG species) on the
activities of these PKCs side by side under the same conditions. We
found that beyond our expectation, the modes of activation of
cPKC and nPKC isozymes by DG molecular species varied
considerably.
We analyzed (1) the sensitivity to DG (DG concentration for
PKC activation), (2) dependence on DG (fold increase in PKC ac-
tivity in the presence of DG), and (3) preference for DG molecular
species of highly puriﬁed cPKC and nPKC isozymes expressed in
the baculovirus-insect cell expression system. (1) Regarding sen-
sitivity to DG, the highly sensitive isozymes are PKCα, PKCβII, PKCγ
and PKCθ (Table 1). (2) PKCθ was the most strongly activated and
PKCα was strongly activated (Table 1). The activities of cPKC and
nPKC isozymes in the presence of DG species were comparable to
those in the presence of TPA (Suppl. Fig. 1). Therefore, the activities
at 2000 mmol% DG are roughly maximal values. (3) PKCα showed
less preference to long/unsaturated fatty acid-containing DG spe-
cies (18:0/22:6-DG) (Table 1). PKCγ, On the other hand, PKCδ, PKCε
and PKCθ showed a preference for long/unsaturated fatty acid-
containing DG species (18:0/22:6-DG) (Table 1). Moreover, these
preferences appear at different DG concentrations. The activation
capacity of saturated and polyunsaturated fatty acid-containing
DG molecular species is suggested to rely on the ﬂuidity state of
the micelles and membranes [36]. Taken together, these results
indicate that c/nPKCs have different sensitivities and dependences
on DG and a distinct preference for shorter and saturated fatty
acid-containing and longer and polyunsaturated fatty acid-con-
taining DG species, respectively (Table 1).
PKCη was not activated by 2–2000 mmol% DG in our assay
conditions (Fig. 6). In addition, this isozyme was not activated by
TPA (data not shown). Because PKCη showed relatively high spe-
ciﬁc activity in the absence of DG compared with the otherisozymes (Fig. 6), this isoform may be already activated in the
absence of DG/TPA. Unlike the insect cell-expressed enzyme, the
mammalian cell-expressed PKCη was activated by DG (Fig. 7).
Essentially the same results (activated at 2 mmol% DG and ap-
proximately 6-fold activated at 2000 mmol% DG) were obtained
using PKCα expressed in mammalian cells (data not shown)
compared to the insect cell-expressed enzyme (Fig. 1). The results
suggest that in the case of PKCη, some modiﬁcation in mammalian
COS-7 cells, but not in insect cells, is needed for the enzyme to
exhibit DG-dependent activation.
It has been claimed that DGs with saturated chains were less
effective on triggering PKC activation than those bearing poly-
unsaturated chains [36–41]. Moreover, Madani et al. [32] reported
that the in vitro activation of different PKC isozymes varies in re-
sponse to different DG species. However, in this report, only PKCα,
βI, γ, δ and ε were analyzed. Moreover, only 8:0/8:0-, which is not
a natural product, 18:0/20:4-, 18:0/20:5- and 18:0/22:6-DG were
used. Furthermore, approximately 50–1000 mmol% of DG species
were tested. In the present study, we more comprehensively
analyzed the effects of a wide range of physiological DG molecular
species and concentrations (2–2000 mmol% 16:0/16:0-, 16:0/18:1-,
18:1/18:1-, 18:0/20:4- or 18:0/22:6-DG species) on the activities of
cPKC (α, βII and γ) and nPKC (δ, ε, η and θ) isozymes (Table 1) side
by side under the same conditions, and identiﬁed several addi-
tional intriguing differences, as described above. For example, we
showed, for the ﬁrst time, that PKCα showed less of a preference
for polyunsaturated fatty acid-containing DG species (18:0/22:6-
DG) at 2 mmol% and that PKCθ has a higher sensitivity and
stronger dependence on DG than the other isozymes.
The results obtained in the present study allow us to speculate
a correlation between the PKC isozymes and DGK isozymes. DGKε
has preference for polyunsaturated fatty acid-containing DG such
as 18:0/20:4-DG [28,29], suggesting possible linkages with PKCγ,
δ, ε and θ, which have preferences for polyunsaturated fatty acid-
containing DG species. DGKα was shown to phosphorylate 18:0/
20:4-DG and 18:0/22:6-DG in cells [30,31]. Therefore, DGKα may
be associated with PKCγ, δ, ε and θ. DGKα is predominantly ex-
pressed in T-lymphocytes [42] and regulates T-cell activation
[15,16]. Of PKCγ, δ, ε and θ, PKCθ is predominantly expressed in
T-lymphocytes and is a key molecule in T-cell activation and dif-
ferentiation [43], implying an intimate linkage between DGKα and
PKCθ. However, further studies are required to deﬁnitely indicate
the relation between DGKs and PKCs.
DGKδ contributes to hyperglycemia-induced peripheral insulin
resistance [17] and regulates the activities of PKCα [18] and PKCδ
[17] in myotubes. Palmitic acid (16:0)-containing DG species are
known to accumulate in skeletal muscle of type 2 diabetes pa-
tients [44]. We showed that DGKδ indeed utilized PC-derived,
palmitic acid-containing DG species (14:0/16:0-, 16:0/16:0-, 16:0/
16:1-, 16:0/18:0-, and 16:0/18:1-DG) [19]. The results are not in-
consistent with the DG species preferences of PKCα and PKCδ
(Figs. 1 and 4 and Table 1).
In the present study, we comprehensively analyzed the effects
of different DG species on cPKC and nPKC isozymes side by side
under the same conditions and revealed that these PKCs have
different dependencies/sensitivities to DG and distinct preferences
for shorter and saturated fatty acid- and longer and poly-
unsaturated fatty acid-containing DG molecular species, respec-
tively. This differential regulation would be important for their
physiological functions. The comprehensive in vitro results ob-
tained in the present study could be a useful guide for interpreting
the activation and functional signiﬁcance of cPKC and nPKC iso-
zymes in vivo.
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